• FDA approves Sandoz’s biosimilar of Humira pharmaceutical
    November 19, 2018
    The US Food and Drug Administration (FDA) has approved Novartis subsidiary Sandoz’s biosimilar of AbbVie’s Humira, Hyrimoz, for seven indications: rheumatoid arthritis...
PharmaSources Customer Service